vigil sanofi - Search News

News

Sanofi buys Vigil Neuroscience for $470m

Seeking Alpha on MSN · 2d

Sanofi to buy Vigil Neuroscience in $470M deal (update)

Sanofi (NASDAQ:SNY) said Wednesday it agreed to acquire clinical-stage biotechnology company Vigil Neuroscience (NASDAQ:VIGL) for $470M in cash, potentially reaching $600M with milestone payments. Following a trading halt,

The Wall Street Journal on MSN · 2d

Sanofi to Buy Vigil Neuroscience for About $470 Million

Sanofi has entered an agreement to acquire Vigil Neuroscience for approximately $470 million, adding a new investigational treatment for Alzheimer’s disease to the French pharmaceutical company’s pipeline.

Yahoo Finance · 1d

Vigil Neuroscience to be acquired by Sanofi for $8.00 per share

Vigil Neuroscience (VIGL) and Sanofi (SNY) announced that it has entered into a definitive merger agreement pursuant to which Sanofi will acquire Vigil for an upfront payment of $8.00 per share of common stock in cash.

Fierce Biotech2d

Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race

Sanofi’s 11 months watching over Vigil Neuroscience have led to a $470 million buyout. | Sanofi’s 11 months watching over ...

Sanofi to Acquire Vigil Neuroscience to Expand Neurodegenerative Disease Pipeline

Sanofi is acquiring Vigil Neuroscience, a biotech firm focused on novel neurodegenerative disease therapies, to boost its ...

BioPharma Dive1d

Sanofi gains experimental Alzheimer’s drug through Vigil buyout

Already a Vigil Neuroscience investor, Sanofi has agreed to buy the rest of the biotech’s shares for $8 apiece, representing ...

22h

Sanofi to spend $470M for Watertown biotech’s Alzheimer’s drug

About a year after investing in Vigil Neuroscience Inc., Sanofi is now acquiring the Watertown biotech and its treatment in ...

Sanofi acquisition adds Alzheimer’s drug to pipeline

From my colleague Adam Feuerstein: French drug maker Sanofi is acquiring the small biotech Vigil Neuroscience for $470 ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results